Shared Gene Targets of the ATF4 and p53 Transcriptional Networks

Gabriele Baniulyte1, Serene A Durham1, Lauren E Merchant1

  • 1Department of Biological Sciences, The RNA Institute, University at Albany, State University of New York, Albany, New York, USA.

PubMed

Insights

Restoring tumor suppressor p53 activity or stimulating the integrated stress response (ISR) can induce cancer cell death. These pathways independently regulate shared genes, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53 tumor suppressor is crucial for cell cycle arrest and apoptosis, and its dysfunction is common in cancer.
  • Restoring p53 activity for tumor-specific cell death is a promising anticancer strategy.
  • The integrated stress response (ISR) offers a p53-independent pathway for potential therapeutic intervention.

Purpose of the Study:

  • To investigate the gene regulatory mechanisms of a p53-independent anticancer strategy targeting the ISR.
  • To understand how p53 and ISR pathways converge to regulate common genes.
  • To identify key transcription factors involved in the shared regulation of metabolic and proapoptotic genes.

Main Methods:

  • Analysis of gene regulatory elements bound by p53 and ATF4 (an ISR effector).
  • Investigating the architecture of shared gene regulatory networks.
  • Identifying transcription factors controlling basal and stress-induced gene expression.

Main Results:

  • The p53 and ISR pathways independently regulate common metabolic and proapoptotic genes.
  • Detailed architecture of gene regulatory elements controlled by p53 and ATF4 was elucidated.
  • Additional transcription factors contributing to the regulation of shared target genes were identified.

Conclusions:

  • The p53 and ISR pathways converge on shared target genes, offering a p53-independent therapeutic avenue.
  • Understanding these gene regulatory networks provides insights into novel anticancer strategies.
  • Identified transcription factors represent potential targets for antitumor therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K